INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 166 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $555,255 | +96298.4% | 18,223 | 0.0% | 0.00% | -25.0% |
| Q3 2023 | $576 | -22.5% | 18,223 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $743 | +32.9% | 18,223 | +21.4% | 0.01% | +25.0% |
| Q1 2023 | $559 | +2.0% | 15,012 | -4.4% | 0.00% | 0.0% |
| Q4 2022 | $548 | -99.9% | 15,700 | -5.5% | 0.00% | -42.9% |
| Q3 2022 | $929,000 | +46.1% | 16,609 | +35.2% | 0.01% | +40.0% |
| Q2 2022 | $636,000 | -28.8% | 12,282 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $893,000 | -40.0% | 12,282 | 0.0% | 0.01% | -37.5% |
| Q4 2021 | $1,489,000 | -10.2% | 12,282 | -0.6% | 0.01% | -11.1% |
| Q3 2021 | $1,658,000 | -23.7% | 12,357 | -69.1% | 0.01% | -40.0% |
| Q4 2020 | $2,172,000 | +176.0% | 39,935 | +0.9% | 0.02% | +150.0% |
| Q3 2020 | $787,000 | +4042.1% | 39,571 | +4331.2% | 0.01% | – |
| Q2 2020 | $19,000 | – | 893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
| Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
| Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
| Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
| Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
| GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
| ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |